Navigation Links
D-Ribose Helps Energy-Starved Hearts
Date:4/28/2008

Doctors recommend Corvalen(R) D-Ribose to boost cellular energy

NEW YORK, April 28 /PRNewswire/ -- Ever been so tired you felt like you could sleep all year and not catch up? That's how Holly Jacobson, a nurse in Clermont, Florida, felt every day. But there was a good reason to be exhausted -- five boys under the age of nine. Nothing a good night's sleep couldn't fix.

Then came a sixth son, and she began experiencing palpitations, breathlessness and fatigue whenever she played with the kids or went for a walk with her husband. And even after eight hours of sleep, she couldn't shake the exhaustion. During the day, her brain was so foggy she couldn't think straight.

One night, Holly woke up with her heart racing. The next day she called the doctor, who gave her bad news: She had a mild heart problem. But there was good news: It could be corrected with a procedure called EECP that required 35 visits to the doctor and cost around $10,000. The complication was that her insurance company didn't like the price tag and dragged its feet on the approval. In the meantime, her cardiologist Ken Kronhouas MD, Ph.D., recommended a less costly but effective therapy.

"Try taking Corvalen(R) D-ribose." This natural 5-carbon sugar is a product used by many health care practitioners, he explained, because it rebuilds critical energy stores in the body. It is a natural and safe treatment without side effects.

Even though she was skeptical of supplements, anything was worth a try. She started mixing a scoop of the powder into her orange juice, and after a week, Holly was waking up refreshed and feeling like her old self again. Two years later, with her heart problem behind her, Holly still takes Corvalen(R) because it gives her the energy she needs to keep up with her six boys.

"Corvalen(R) D-ribose gives me energy to spare," says Holly. "Not just to get through my days, but to enjoy every minute of them."

According to New York cardiovascular specialist Fred Vagnini, MD (http://www.vagnini.com), "Any patient with heart muscle weakness will benefit from Corvalen(R) D-ribose because it addresses the 'energy crisis' at the cellular level.

"Corvalen(R) stimulates the synthesis of adenosine triphosphate (ATP), an essential energy compound found in every cell in the body," explains Dr. Vagnini, author of Count Down Your Age (McGraw-Hill, 2007). "ATP is critical to health and maintaining normal energy-related body functions, and ribose is the essential component in the making of ATP."

Corvalen(R) D-ribose is a product of Bioenergy Life Science, Inc. (http://www.bioenergy.com) a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose in health and wellness.


'/>"/>
SOURCE Bioenergy Life Science, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
2. NASA technology helps predict and prevent future pandemic outbreaks
3. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
4. New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance
5. Edison Innovation Fund Helps Tris Pharma Expand
6. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... February 16, 2017 Patient ... of innovative telemedicine application, new and leading edge ... experiencing a boom worldwide. The healthcare sector as ... technologies, services and new therapies for companies such ... RHT), Cellectar Biosciences, Inc. (NASDAQ: CLRB ...
(Date:2/16/2017)... , Feb. 16, 2017  Windtree Therapeutics, ... company focusing on developing aerosolized KL4 surfactant therapies ... a preclinical influenza study showed that aerosolized KL4 ... in a well-established preclinical animal model. The Company ... growing body of evidence that supports the role ...
(Date:2/15/2017)... ... 2017 , ... Park Systems , a leader in Atomic Force Microscopy ... drastically boosts productivity with single click reliable nanoscale images, is now available on Park ... and taking the image once done manually by the operator producing high quality nanoscale ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
Breaking Biology News(10 mins):